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1. Introduction 
In order to explain the insulin-independent work- 
induced acceleration of glucose uptake into skeletal 
muscle [ 1,2], a humoral factor was postulated which 
was supposed to be released by the tissue under these 
circumstances [3]. Recently, kinins liberated from 
kininogen during muscle work were recognized as 
possible candidates for the requested factor 141. This 
was emphasized by almost identical results obtained 
during muscle hypoxia [5] and by the finding that 
the molecular weight estimated for the factor [6] 
was almost identical to that of kinins. 
Since kinin liberation was also supposed to be 
involved in insulin action on glucose uptake into 
resting muscle [7], it appeared of interest o 
investigate whether the well-known permissive action 
of insulin on glucose uptake during muscle work [8] 
will also be impaired when kinin liberation from 
kininogen is prevented. 
2. Materials and methods 
Healthy volunteers (n = 8,4,4) were recruited from 
medical students. They were informed about the aim 
and the possible risks of the study and gave their 
consent according to the Code of Ethics of the World 
Medical Association [9]. Physical examination as well 
as laboratory tests excluded internal diseases. The 
three groups were well comparable as to their age, 
height and weight. All subjects were fasted overnight 
(15 h) and received no drugs or premeditation. 
Under sterile conditions and local anaesthesia an 
Abbocath-T-needle (20-G, Abbot Laboratories, 
North Chicago, IL 60064) was inserted into a brachial 
artery and was flushed continuously with 154 mM 
NaCl(0.2 ml/min) and heparin at a low enough rate 
(0.1 U/kg X min) to exclude a significant effect on 
lipoprotein lipase activity [lo]. Then, one of the 
cubital veins apparently draining deep forearm tissue 
areas was cannulated at the other arm, and a teflon 
catheter (Code 115 12, Vygon) inserted retrograde as 
deep as possible. In addition, brachial artery of this 
arm was cannulated with a Abbocath-T needle (see 
above) and flushed continuously with 154 mM NaCl 
(0.2 mllmin) without heparin. 
After an accommodation period of 1.5 min arterial 
and deep-venous blood samples were collected 
simultaneously throughout a 10 min basal period for 
chemical analysis at S min intervals. 
Then, in 8 subjects, during intrabrachial rterial 
infusion of 154 mM NaCl, rhythmic-isometric 
exercise, standardized by a special ergometer [ 111 
was performed for 3 min (0.82 W). Blood samples 
were obtained at 2.5 min and 3 min during work load 
and 4 min afterwards. During the whole test period 
muscle blood flow was registered continuously [121 
after intramuscular injection of 0.3 mCi ‘33Xe dissolved 
in 0.1 ml saline, counting its washout by a scintillation 
counter (Model 302, Packard). 
In 4 other subjects, after collecting basal blood 
samples, 10 min before starting identical forearm 
work, 1.50 E.~U insulin/kg X min (A&insulin Hoechst 
CS@, Hoechst AC, Frankfurt) dissolved in 154 mM 
NaCl were infused into the bra&al artery of the 
working arm for the whole following test period at 
0.2 mllmin. 3 min after starting insulin infusion 
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1 mg glucose/kg X min (0.555 M sterile glucose solu- 
tion) was applied into an anticubital vein of the non- 
working arm in orde to maintain constant arterial 
glucose level [7]. 
Another 4 subjects received first after the basal 
period infusion of a kallikrein-trypsin inhibitor 
(Trasylol@, containing 500 000 kallikrein inhibitor 
units in 50 ml isotonic solution, Bayer AG, Lever- 
kusen) into an anticubital vein of the non-working 
arm for the whole following test period (500 000 
kallikrein inhibitor units within 15 mm and then 
12 500 kIU/min. At min 10 after starting inhibitor 
infusion identical infusion of insulin into the brachial 
artery of working arm and 3 min later infusion of 
glucose into an anticubital vein of the non-working 
arm was applied. 
In both these groups receiving insulin or inhibitor 
plus insulin, one arterial and deep-venous blood 
sample was taken 8 min after starting insulin infusion. 
Forearm work thereafter started at min 10 and blood 
sampling was done as indicated in the control group. 
Analyses of substrates, insulin and oxygen were 
performed as in [7,13]. Standard statistical methods 
were employed [ 141 using the Student’s t-test for 
paired and unpaired samples when applicable. 
3. Results 
Arterial concentrations of substrates did not 
change during the whole test period and were almost 
identical in all the groups: 
Glucose: control [Cl: 4.74 + 0.09 mmol/l; insulin 
[J]: 4.59 + 0.13 mmol/l; insulin plus inhibitor 
[JJ]: 4.92 f 0.05 mmol/l. 
Lactate: C: 0.41 f 0.03 mmol/l; J: 0.33 +- 0.04; JJ: 
0.41 * 0.07. 
P-hydroxybutyrate: C: 0.15 f. 0.03 mmol/l; J: 
0.22 + 0.04; JJ: 0.10 + 0.03. 
8 min after starting intra-arterial infusion of 
insulin before work identical deep-venous concen- 
trations of insulin were measured in both groups (J: 
100.0 f 43.8, JJ: 139.8 + 37.0 MU/ml). At min 2.5 
during work a slight decrease was found (J: 79.5 f 
24.6, JJ: 94.5 + 29.4 flu/ml). 
The mean values for blood flow and for arterial- 
deep-venous differences of glucose, lactate and oxygen 
are indicated in the table, the values for muscle 
uptake of glucose in the figure. 
Muscle release of lactate was found to be identical 
in the 3 groups at rest and during infusion of insulin 
with and without the inhibitor. However, during work 
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+Basal+p Infusion _) 
h 
2.5 min 3 min 
REST --I_- WORK A&+ 
Fig.1. Glucose uptake into skeletal muscle of forearm. The values were calculated from the arterial-deep-venous glucose differences 
and the corresponding blood flow rates and represent he mean ? SEM. Insulin was infused into the brachial artery, the inhibitor 
(Trasylol@) into an antecubital vein. (a) Indicates significant difference to basal (paired r-test); (b) to control (unpaired t-test) 
and (c) to insulin (unpaired r-test). Further details under section 2. 
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muscle factate release was enhanced up to -4,233 f
0.67 ~~~/~~ g x min in c and only up ta -2,n + 
Q.42 in J and to -f.45 * 0.71 in JJ, Dur&g recovery 
muscle lactate release was found to be lessened in 
JJ f-O,14 f 0.07) as compared to C or J (-0.44 4 
0.08, -0.42 % 0.08). 
Muscle uptake of oxygen was identical during rest 
arxd recovery in the 3 groups. During work, muscle 
oxygen consumption i creased to the same xtent to 
2.08 L?: 0.21 ml/l00 g X min in C and to 1.85 rt 0.27 
in J, but oniy up to 0.87 * 0.09 ml/100 g X min in 33. 
The aim of this study was to investigate whether 
the well-known permissive action af insulin on 
accelerated glucose uptake into skeletal muscle during 
work load [ 81 could be impaired when liberation of 
kinins from kininogen was prevented by the infusion 
of a kalliksein-trypsin inhibitor (see section 2). 
The model employed was previously proven to be 
suitable for this purpose [IS]= ~~ho~~ the “‘axe- 
~je~~o~ technique mployed for the me~uremen~ of 
blood flow is encumbered by sevefa5 dif~cu~t~es, it is 
supposed to yield representative increases of muscle 
blood flow during muscle work fl6]. According to 
the moderate work load, glucose uptake was already 
increased at 2.5 min and 3 min, and the values 
obtained are in good agreement with those in [17], 
Insulin was used at a dose which was already 
observed earlier to give only small changes of glucose 
metabolism in the resting human forearm /38,19]. As 
had been found in the in vitro model [8] the 
acceleration of glucose uptake during muscle work 
was further increased s~gn~~can~ during insulin 
~nf~s~~~, Lesser lactate refease of working muscfe 
under the influence of ins&in was most probably due 
to increased pyruvate oxidation resufting from 
inhibition of muscle lipolysis [20] and consequently 
decreased availability of endogenous free fatty acids 
for oxidation. Both, the effect of work and the 
permissive action of insulin on glucose uptake were 
almost completely abolished by the ktiisein inhibitor 
employed. Identical deep-venous insuhn eoncen- 
trations obtained behind the muscle in both groups 
proved identicaf hormone drive, identical substrate 
44 
supg4y ah comparabfe rnetaboic con~t~ons ( ee 
section 3). Since the work avowed was ~de~tic~~ in 
S the cases, reduced oxygen ut~~a~~on during the 
infusion of the inhibitor was supposed to be rather a 
consequence of prevented glucose uptake especially 
considering the impaired availability of other 
substrates during insulin infusion. 
The inhibition of liberation of kinins from 
kininogen by Al kallikrein inhibitor had been found to 
reduce glucose uptake into muscle during work {4] I
That this effect was really due to inhibition of the 
a&v&y of the enzyme kahikrein was very probable 
since s~bst~t~~o~ of br~dy~n into the bra&al 
artery was abla to restore the normal resays during 
work toad, That the reduced glucose uptake observed 
was not a consequence of reduced oxidative 
metabolism was furthermore strengthened byearlier 
data also showing reduction of insulin-induced 
acceleration of glucose uptake into the resting human 
forearm by the inhibitor employed (7 1, That this was 
due to prevented liberation of kinins from kinmogen 
was underlined by the finding that inhibition of 
prosta~~d~~ biosynthesis which had been found to 
&r&ate the action of k&&s, prevented the action of 
ins&n on glucose uptake to a sim&ir extent x2 1 ] . 
~ever~e~ess~ it has to be discussed fina@ that also 
other kinds of p&eases could have been ~nff~e~ced by 
the inhibitor since trasylol is no specific k~~k~~i~ 
inhibitor [22]. However, since there is no clear 
evidence so far that proteases are involved in insulin 
action [23] inhibition of the activity of the kinino~ 
genase kalhkrein seems to be the most probable 
reason for the observed effect. 
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